James M Mock Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 16 hours ago
James M Mock has an estimated net worth of at least $11.0 million*, as of Aug. 26, 2026. They own 67,139 shares of MRNA stock. They have sold 21,916 shares of MRNA stock since 2021, for an estimated $1.0 million.
James M Mock $MRNA SEC Form 4 Insider Trading
James M Mock has filed a total of 12 insider trades in $MRNA since 2021. Their most recent trade was a sale of 1,420 shares, made on Nov 29, 2024. Their largest trade was a sale of 2,858 shares, made on Oct 06, 2023. We estimate that they now own 67,139 shares of $MRNA, worth an estimated $10.0 million.
Insider Trading at $MRNA
There have been a total of 1451 insider trades reported at $MRNA since 2021, with 191,934 shares purchased and 9.6 million shares sold. The most active insider traders in $MRNA stock have been Stephane Bancel, Stephen Hoge, and Juan Andres. The most recent trade was a sale of 39,891 shares reported by Stephane Bancel (Chief Executive Officer), made on Aug 05, 2026.
History of Insider Stock Trades by James M Mock
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MRNA
|
Sale | 1,420 | Nov 29, 2024 | Dec. 2, 2024, 5:26 p.m. |
|
MRNA
|
Sale | 715 | Oct 07, 2024 | Oct. 8, 2024, 4:19 p.m. |
|
MRNA
|
Sale | 162 | Aug 29, 2024 | Aug. 30, 2024, 4:37 p.m. |
|
MRNA
|
Sale | 1,321 | Aug 28, 2024 | Aug. 29, 2024, 4:45 p.m. |
|
MRNA
|
Sale | 689 | Jul 08, 2024 | July 9, 2024, 4:34 p.m. |
|
MRNA
|
Sale | 691 | Jun 03, 2024 | June 4, 2024, 5:27 p.m. |
|
MRNA
|
Sale | 183 | May 29, 2024 | May 30, 2024, 4:36 p.m. |
|
MRNA
|
Sale | 648 | May 28, 2024 | May 29, 2024, 4:16 p.m. |
|
MRNA
|
Sale | 705 | Apr 08, 2024 | April 9, 2024, 4:09 p.m. |
|
MRNA
|
Sale | 647 | Feb 29, 2024 | March 1, 2024, 6:33 p.m. |
|
MRNA
|
Sale | 772 | Jan 08, 2024 | Jan. 9, 2024, 5:08 p.m. |
|
MRNA
|
Sale | 2,858 | Oct 06, 2023 | Oct. 10, 2023, 4:51 p.m. |
PKI
|
Sale | 2,072 | Jun 24, 2022 | June 26, 2022, 8 p.m. |
|
PKI
|
Sale | 2,290 | Jun 24, 2022 | June 26, 2022, 8 p.m. |
|
PKI
|
Sale | 663 | Jun 24, 2022 | June 26, 2022, 8 p.m. |
|
PKI
|
Sale | 1,300 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
|
PKI
|
Sale | 1,803 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
|
PKI
|
Sale | 1,377 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
|
PKI
|
Sale | 400 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
|
PKI
|
Sale | 1,100 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
|
PKI
|
Sale | 100 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
$MRNA Executives and Stock Owners with Insider Trades
-
Stephane Bancel, Chief Executive Officer
-
Stephen Hoge, President
-
Juan Andres, See remarks
-
Shannon Thyme Klinger, Chief Legal Officer
-
James M Mock, Chief Financial Officer
-
Tal Zvi Zaks, Chief Medical Officer
-
Arpa Garay, Chief Commercial Officer
-
David W Meline, Chief Financial Officer
-
Paul Burton, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.